Paper40201683
Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.
Li Y and 7 others. Front Pharmacol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study. Papers, record 40201683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40201683
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33039854 | Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease. | Clin Neurol Neurosurg | 2020 | https://conductscience.org/library/papers/33039854 | PubMed |
| 2 | 33250838 | Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease. | Front Neurol | 2020 | https://conductscience.org/library/papers/33250838 | PubMed |
| 3 | 21663922 | Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. | J Neurol Sci | 2011 | https://conductscience.org/library/papers/21663922 | PubMed |
| 4 | 15115919 | A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. | Pharmacogenetics | 2004 | https://conductscience.org/library/papers/15115919 | PubMed |
| 5 | 21278619 | Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21278619 | PubMed |
| 6 | 27751556 | The epidemiology of Parkinson's disease: risk factors and prevention. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27751556 | PubMed |
| 7 | 27817855 | Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists. | J Neurol Sci | 2017 | https://conductscience.org/library/papers/27817855 | PubMed |
| 8 | 27190009 | Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study. | Brain | 2016 | https://conductscience.org/library/papers/27190009 | PubMed |
| 9 | 32022467 | Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease. | Brain Behav | 2020 | https://conductscience.org/library/papers/32022467 | PubMed |
| 10 | 37801319 | Multigenetic Pharmacogenomics-Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37801319 | PubMed |
| 11 | 15355491 | The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease. | Acta Neurol Scand | 2004 | https://conductscience.org/library/papers/15355491 | PubMed |
| 12 | 15640376 | Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney. | Drug Metab Dispos | 2005 | https://conductscience.org/library/papers/15640376 | PubMed |
| 13 | 35079903 | Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis. | Neurol Sci | 2022 | https://conductscience.org/library/papers/35079903 | PubMed |
| 14 | 30677646 | Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. | J Psychiatr Res | 2019 | https://conductscience.org/library/papers/30677646 | PubMed |
| 15 | 23565891 | Anti-Parkinson's disease drugs and pharmacogenetic considerations. | Expert Opin Drug Metab Toxicol | 2013 | https://conductscience.org/library/papers/23565891 | PubMed |
| 16 | 33641259 | Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. | Clin Transl Sci | 2021 | https://conductscience.org/library/papers/33641259 | PubMed |
| 17 | 25686762 | Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. | Pharmacogenomics J | 2015 | https://conductscience.org/library/papers/25686762 | PubMed |
| 18 | 21280081 | The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. | Ann Neurol | 2011 | https://conductscience.org/library/papers/21280081 | PubMed |
| 19 | 9204539 | Opossum kidney cells take up L-DOPA through an organic cation potential-dependent and proton-independent transporter. | Cell Biol Int | 1997 | https://conductscience.org/library/papers/9204539 | PubMed |
| 20 | 18698234 | The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. | Pharmacogenet Genomics | 2008 | https://conductscience.org/library/papers/18698234 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41222708 | Pharmacogenetics in advanced Parkinson's disease. | J Neural Transm (Vienna) | 2025 | https://conductscience.org/library/papers/41222708 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40201683
GET https://conductscience.org/api/papers/v1/40201683/references?page=2